|
[ X
|
]
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] FOR THE FISCAL YEAR ENDED JUNE 30, 2024, OR
|
|
[
|
]
|
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] for the transition period from _________ to__________.
|
A.
|
Full title of the plan and the address of the plan, if different from that of the issuer named below: Procter & Gamble Ireland Employees Share Ownership Plan (1998), c/o Irish Pensions
Trust Limited, 25/28 Adelaide Road, Dublin 2, Ireland.
|
B.
|
Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: The Procter & Gamble Company, One Procter & Gamble Plaza, Cincinnati,
Ohio 45202
|
Item 1.
|
Audited statements of financial condition as of the end of the latest two fiscal years of the plan (or such lesser period as the plan has been in existence).
|
Item 2.
|
Audited statements of income and changes in plan equity for each of the latest three fiscal years of the plan (or such lesser period as the plan has been in existence).
|
PROCTER & GAMBLE
IRELAND
EMPLOYEES SHARE
OWNERSHIP PLAN (1998)
Statements of Net Assets Available for Plan
Benefits as of June 30, 2024 and 2023,Statements
of Changes in Net Assets Available for Plan
Benefits for the Years Ended June 30, 2024, 2023
and 2022, and Report of Independent Registered
Public Accounting Firm
|
TABLE OF CONTENTS | ||
Page | ||
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 1 | |
FINANCIAL STATEMENTS: | ||
Statements of Net Assets Available for Plan Benefits as of June 30, 2024 and 2023 | 2 | |
Statements of Changes in Net Assets Available for Plan Benefits for the Years Ended June 30, 2024, 2023 and 2022
|
3 | |
Notes to Financial Statements as of June 30, 2024 and 2023 and for the Years Ended June 30, 2024, 2023 and 2022 | 4 |
/s/ Deloitte LLP
|
|
2024
|
2023
|
|
|
€
|
€
|
ASSETS:
|
|
|
|
Investment in The Procter & Gamble Company common stock, at fair value (11,154 shares at 30 June 2024, 16,695 shares at 30 June 2023)
|
|
1,717,815
|
2,330,965
|
Cash at bank and in hand
|
71,399
|
71,009
|
|
Total assets
|
1,789,214
|
2,401,974
|
|
LIABILITIES:
|
|
||
Distributions payable (Note 5)
|
|
(12,325)
|
(16,659)
|
Total liabilities
|
|
(12.325)
|
(16,659)
|
|
|
||
NET ASSETS AVAILABLE FOR PLAN BENEFITS
|
|
1,776,889
|
2,385,315
|
|
2024
|
2023
|
2022
|
|
€
|
€
|
€
|
ADDITIONS:
|
|
|
|
|
|
|
|
Contributions:
|
|||
Employer contributions (Note 8)
|
85,839
|
76,124
|
358,294
|
Employee contributions
|
85,839
|
76,124
|
358,294
|
Total Contributions
|
171,678
|
152,248
|
716,588
|
Investment Income:
|
|||
Realised gain on investments sold (Note 4)
|
92,558
|
57,323
|
160,291
|
Net appreciation in fair value of investment (Note 4)
|
51,259
|
1,288
|
420,147
|
Dividend Income (Note 8)
|
44,036
|
61,851
|
70,303
|
Total Investment Income
|
187,853
|
120,462
|
650,741
|
Income from participating Procter & Gamble companies (Note 7)
|
179
|
210
|
1,111
|
Total Additions
|
359,710
|
272,920
|
1,368,440
|
|
|||
DEDUCTIONS:
|
|||
Distributions and withdrawals to participants
|
(967,957)
|
(824,637)
|
(1,344,998)
|
Administrative expenses
|
(179)
|
(210)
|
(1,111)
|
Total Deductions
|
(968,136)
|
(824,847)
|
(1,346,109)
|
|
|||
NET (DECREASE)/INCREASE IN NET ASSETS
|
(608,426)
|
(551,927)
|
22,331
|
|
|||
NET ASSETS AVAILABLE FOR PLAN BENEFITS:
|
|||
Beginning of year
|
2,385,315
|
2,937,242
|
2,914,911
|
|
|||
End of year
|
1,776,889
|
2,385,315
|
2,937,242
|
|
|
|
|
1. |
DESCRIPTION OF THE PLAN
|
2. |
SIGNIFICANT ACCOUNTING POLICIES
|
3. |
FAIR VALUE MEASUREMENT
|
3. |
FAIR VALUE MEASUREMENT (continued)
|
Level 1
|
Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the plan has the ability to access.
|
|
Level 2
|
Inputs to the valuation methodology include
• quoted prices for similar assets or liabilities in active markets;
• quoted prices for identical or similar assets or liabilities in inactive markets;
• inputs other than quoted prices that are observable for the asset or liability;
• inputs that are derived principally from or corroborated by observable market data by correlation or other means.
If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.
|
|
Level 3
|
Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
|
4. |
INVESTMENTS
|
|
2024
|
2023
|
2022
|
||
|
€
|
€
|
€
|
||
The Procter & Gamble Company
|
|
|
|
||
common stock
|
|||||
Net appreciation
|
51,259
|
1,288
|
420,147
|
|
2024
|
2023
|
2022
|
||
|
€
|
€
|
€
|
||
Proceeds on sales of shares
|
462,141
|
247,488
|
620,739
|
||
Cost
|
(369,583)
|
(190,165)
|
(460,448)
|
||
Realised gain on sales of shares
|
92,558
|
57,323
|
160,291
|
5. |
DISTRIBUTIONS PAYABLE
|
6. |
FEDERAL INCOME TAX STATUS
|
7. | PARTICIPATING PROCTER & GAMBLE COMPANIES |
•
|
Procter & Gamble (Manufacturing) Ireland Limited;
|
•
|
Procter & Gamble (HABC) Limited; and
|
•
|
Procter & Gamble (L&CP) Limited
|
8. |
RELATED PARTY TRANSACTIONS
|
9. |
PLAN TERMINATION
|
10. |
SUBSEQUENT EVENTS
|